GICS Sector : Healthcare
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel.The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services.It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues.
Marpari's financial performance in Q3 2025 was marked by a significant decline in net revenues, which came in at $4 million, a 42% decrease from Q3 2024. Operating expenses, however, showed a 24% improvement, resulting in an operating loss of $3.5 million, a 2% improvement from the same period last year. The net loss was $3 million, with basic and diluted loss per share at $0.20, missing analyst estimates of -$0.09. The company's actual EPS was -$0.20, indicating a challenging quarter.
Publication Date: Nov -23
Despite the decline in revenues, Marpai made significant progress in reducing its cash burn, with $450,000 in unrestricted cash on hand at the end of Q3. The recent $3.9 million private investment in public equity (PIPE) transaction is expected to provide the necessary financial strength to fund the final stages of its turnaround plan. CEO Damien Lamendola's investment of $1.7 million in Q3 reflects his confidence in the company's hypergrowth strategy and potential for sustainable profitability.
Analysts estimate Marpai's revenues to grow by 98.2% next year, indicating a strong potential for recovery. With a current P/S Ratio of 0.58, the market seems to be pricing in a significant improvement in revenues. Additionally, the EV/EBITDA ratio stands at -1.25, suggesting that the market expects the company to return to profitability. The company's ROE stands at 41.26%, indicating a strong potential for returns on equity. As Marpai continues to drive new efficiencies and roll out its Empara client experience tool, the stage is set for a pivot from recovery to an aggressive sustainable growth phase.
Marpai's Q3 2025 earnings report highlights the company's ongoing efforts to reduce costs and improve operational efficiency. With a strong total addressable market in the TPA industry and a growing demand for self-funded plans, Marpai is well-positioned to capitalize on the trend. As the company completes its rollout of the Empara client experience tool and drives new efficiencies, investors can expect a more sustainable growth trajectory in the future.
MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION
Dec -01
Marpai, Inc. (MRAI) Q3 2025 Earnings Call Transcript
Nov -13
MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Nov -12
MARPAI TO HOST WEBCAST ON NOVEMBER 13, 2025 TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS
Nov -06
MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR
Oct -14
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
Oct -06
Marpai, Inc. (MRAI) Q2 2025 Earnings Call Transcript
Aug -14
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Aug -13
Marpai, Inc.'s 10.47% growth in Third Party Administrator Services is driven by increasing demand for cost-effective healthcare management, expansion into new markets, and strategic partnerships. Additionally, the company's innovative technology and data analytics capabilities have improved operational efficiency, enabling it to attract and retain clients.
Marpai's Captive Insurance growth of 11.47% is driven by increasing adoption of alternative risk management strategies, expansion into new industries, and rising demand for customized insurance solutions. Additionally, Marpai's data-driven approach and AI-powered underwriting capabilities are attracting mid-sized businesses seeking more efficient and cost-effective risk management solutions.
A healthcare management platform that provides a comprehensive suite of tools for healthcare providers to manage patient care, claims, and billing.
A health insurance platform that offers customizable insurance products and risk management solutions for employers and individuals.
A data analytics platform that provides insights and predictive modeling for healthcare providers, payers, and employers.
A care management platform that provides personalized care coordination and navigation services for patients with complex needs.
Marpai, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the evolving nature of the healthcare industry.
Marpai, Inc.'s customers are primarily self-insured employers and health plans, which have limited bargaining power due to the company's specialized services.
Marpai, Inc. relies on a network of healthcare providers and suppliers, which have some bargaining power due to the company's dependence on their services.
The healthcare industry is highly competitive, and new entrants can easily disrupt the market, posing a significant threat to Marpai, Inc.'s market share.
The healthcare industry is highly competitive, and Marpai, Inc. faces intense rivalry from established players and new entrants, which can lead to pricing pressures and market share erosion.
| Value | |
|---|---|
| Debt Weight | -45.40% |
| Debt Cost | 30.70% |
| Equity Weight | 145.40% |
| Equity Cost | 30.70% |
| WACC | 30.70% |
| Leverage | -31.23% |
Value: 9.4
Growth: 3.9
Quality: 5.4
Yield: 0.0
Momentum: 9.0
Volatility: 0.7
1-Year Total Return ->
Value: 3.4
Growth: 6.8
Quality: 3.3
Yield: 0.0
Momentum: 9.0
Volatility: 3.7
1-Year Total Return ->
Value: 6.4
Growth: 2.0
Quality: 4.6
Yield: 0.0
Momentum: 9.0
Volatility: 3.7
1-Year Total Return ->
Value: 4.6
Growth: 4.8
Quality: 2.5
Yield: 1.0
Momentum: 8.0
Volatility: 1.3
1-Year Total Return ->
Value: 6.8
Growth: 3.4
Quality: 3.2
Yield: 0.0
Momentum: 5.5
Volatility: 1.0
1-Year Total Return ->
Value: 8.8
Growth: 1.3
Quality: 3.4
Yield: 0.0
Momentum: 0.0
Volatility: 3.3
1-Year Total Return ->